Equitable Holdings, Inc. (EQH) Balance Sheet

The balance sheet is liability-driven in the most literal sense: total liabilities of $333.4B now absorb all but a $1.3B sliver of the $334.7B asset base, down from roughly $6.2B of net assets in 2024Q1. Because reserves and policyholder obligations scale with the asset side while equity is effectively zero-to-negative, every quarter of underwriting or hedging loss lands with nearly full leverage, which appears to be what the -26.1% 2026Q2 ROE reflects rather than a deterioration in premium collection. Investors should monitor whether equity stabilizes near zero or continues to erode as the Corebridge merger draws capital.

The pattern of claims spiking to $1.7B in 2025Q3, collapsing to $391M by 2025Q4, and re-appearing as a 129.7% combined ratio in 2026Q2 suggests that reported reserve activity is being punctuated by large, discrete remeasurement events rather than by steady loss emergence. For a long-duration life and annuity writer, this kind of lumpy behavior is consistent with hedging marks, DAC unlocking, or LDTI reserve remeasurement flowing through the statutory result, though the underlying liability adequacy cannot be confirmed from these figures alone. The key judgment issue is whether the 2025Q3 loss cluster was genuinely one-time, which materially affects how much of the -26.1% ROE is structural versus episodic.

With equity near zero, the 3.67 debt-to-equity ratio is less a statement about leverage in the conventional sense than an artifact of an almost fully depleted equity base, which leaves the subsidiary debt stack resting on a very thin consolidated cushion. Statutory capital adequacy, not the GAAP equity figure, will determine whether EQH can fund buybacks, absorb merger integration costs, or hold its ratings, and the dataset does not disclose RBC ratios or statutory surplus, so this determination warrants further investigation in regulatory filings. The absence of buyback capacity in the event of another 2025Q3-style loss quarter is the practical implication investors should weigh against the Corebridge combination.

Claims and benefits payable, the most visible liquidity claim on the balance sheet, fell to $420M in 2026Q2 from $1.6B a year earlier, which on its face suggests near-term payout pressure has eased relative to the 2025Q3 spike. However, with cash balances blank across all ten quarters and the invested-asset line reported at an implausible constant, the customary test of liquid assets against expected policyholder payouts cannot be performed from the data provided. Analysts should therefore anchor liquidity conclusions on statutory filings showing general account composition, reinsurance recoverables, and unrestricted subsidiary cash rather than on this snapshot.